Project Number 5R01AG058660-02 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for A Randomized; Double-blind; Placebo-Controlled; Parallel-Group; Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator CATALANO, SUSAN M Principal Investigator First Name SUSAN Principal Investigator Last Name CATALANO Awardee Organization Cognition Therapeutics, Inc. Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-365: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01) FY Overall Cost $5,735,586 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
